Compare BBW & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBW | STRO |
|---|---|---|
| Founded | 1997 | 2003 |
| Country | United States | United States |
| Employees | N/A | 133 |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.3M | 524.8M |
| IPO Year | 2004 | N/A |
| Metric | BBW | STRO |
|---|---|---|
| Price | $37.35 | $29.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $67.71 | $31.33 |
| AVG Volume (30 Days) | ★ 334.4K | 291.3K |
| Earning Date | 05-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.51% | N/A |
| EPS Growth | ★ 5.00 | N/A |
| EPS | ★ 3.99 | N/A |
| Revenue | ★ $357,866,000.00 | N/A |
| Revenue This Year | $5.63 | N/A |
| Revenue Next Year | $4.62 | N/A |
| P/E Ratio | $9.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $34.08 | $0.67 |
| 52 Week High | $75.77 | $43.85 |
| Indicator | BBW | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 42.12 |
| Support Level | $35.31 | $10.50 |
| Resistance Level | $39.71 | $43.85 |
| Average True Range (ATR) | 1.95 | 3.21 |
| MACD | 0.32 | -1.22 |
| Stochastic Oscillator | 53.61 | 22.83 |
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.